ACCOLATE TAB 20 MG TABLET Kanada - englanti - Health Canada

accolate tab 20 mg tablet

astrazeneca canada inc - zafirlukast - tablet - 20mg - zafirlukast 20mg - leukotriene modifiers

ESCITALOPRAM 5 Milligram Film Coated Tablet Irlanti - englanti - HPRA (Health Products Regulatory Authority)

escitalopram 5 milligram film coated tablet

cipla (eu) limited - escitalopram oxalate - film coated tablet - 5 milligram - selective serotonin reuptake inhibitors

ESCITALOPRAM 10 Milligram Film Coated Tablet Irlanti - englanti - HPRA (Health Products Regulatory Authority)

escitalopram 10 milligram film coated tablet

cipla (eu) limited - escitalopram oxalate - film coated tablet - 10 milligram - selective serotonin reuptake inhibitors

ESCITALOPRAM 20 Milligram Film Coated Tablet Irlanti - englanti - HPRA (Health Products Regulatory Authority)

escitalopram 20 milligram film coated tablet

cipla (eu) limited - escitalopram oxalate - film coated tablet - 20 milligram - selective serotonin reuptake inhibitors

Kalinox 50 % / 50 % Medicinsk gas, komprimerad Ruotsi - englanti - Läkemedelsverket (Medical Products Agency)

kalinox 50 % / 50 % medicinsk gas, komprimerad

KALINOX 50%/50% Gas zur medizinischen Anwendung, druckverdichtet Saksa - englanti - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

kalinox 50%/50% gas zur medizinischen anwendung, druckverdichtet

MOVANTIK- naloxegol oxalate tablet, film coated Yhdysvallat - englanti - NLM (National Library of Medicine)

movantik- naloxegol oxalate tablet, film coated

valinor pharma, llc - naloxegol oxalate (unii: 65i14tnm33) (naloxegol - unii:44t7335bke) - movantik® is indicated for the treatment of opioid-induced constipation (oic) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. movantik is contraindicated in: risk summary limited available data with movantik use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. movantik may precipitate opioid withdrawal in the pregnant women and the fetus (see clinical considerations) . in animal development studies, no effects on embryo-fetal development were observed following administration of naloxegol in pregnant rats during the period of organogenesis at doses up to 1452 times the human auc (area under the plasma concentration-time curve) at the maximum recommended human dose. no effects on embryo-fetal development were observed following administration of naloxegol in pregnant rabbits during the period of organogenesis at

CALINOR-5 - TAB Intia - englanti - Central Drugs Standard Control Organization

calinor-5 - tab

calibar ph. - tab - -

Kalinox gas cylinder Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kalinox gas cylinder

air liquide santé international s.a. - nitrous oxide 50 %; oxygen 50 % - inhalation gas - 170 bar - nitrous oxide; oxygen - nitrous oxide

ALINOR 14 TAB Intia - englanti - Central Drugs Standard Control Organization

alinor 14 tab

vhb(cronus) - atenolol - tab - 100mg - 14